4.1 Article

Changes in Levels of Biomarkers Associated with Adipocyte Function and Insulin and Glucagon Kinetics During Treatment with Dapagliflozin Among Obese Type 2 Diabetes Mellitus Patients

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Glycemic Targets

[Anonymous]

DIABETES CARE (2015)

Article Medicine, Research & Experimental

Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production

Aurora Merovci et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Medicine, Research & Experimental

Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients

Ele Ferrannini et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Endocrinology & Metabolism

Effects of a community-based weight loss intervention on adipose tissue circulating factors

Gary D. Miller et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2014)

Article Medicine, General & Internal

Impact of Sodium Glucose Cotransporter 2 Inhibitors on Weight in Patients With Type 2 Diabetes Mellitus

Anthony H. Barnett

POSTGRADUATE MEDICINE (2013)

Article Endocrinology & Metabolism

Enhanced expressions of sodium–glucose cotransporters in the kidneys of diabetic Zucker rats

Niloofar M. Tabatabai et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2008)

Review Endocrinology & Metabolism

Renal gluconeogenesis - Its importance in human glucose homeostasis

JE Gerich et al.

DIABETES CARE (2001)